Russia's Fastest CRO and clinical trials in Russia - Synergy Research Group (Synergy). - Home

+++ SEPTEMBER 2016: LAST PATIENT IS RANDOMIZED INTO PHASE III STUDY IN PATIENTS WITH FUNCTIONAL DYSPEPSIA +++ JULY 2016: THE FIRST PATIENT IS RANDOMIZED INTO PHASE III STUDY IN PATIENTS WITH OVERACTIVE BLADDER +++ NEW PHASE III STUDY IN POSTMENOPAUSAL WOMEN WITH VMS STARTED +++ JUNE 2016: CLINICAL DATABASE IS LOCKED IN TIME IN THE PHASE III STUDY +++ NEW RETROSPECTIVE NON-INTERVENTIONAL STUDY IN PATIENTS WITH THE ACUTE SKIN  INFECTION STARTED +++ THE RUSSIAN AND UKRAINIAN MoH APPROVED OUR PHASE III STUDY IN PATIENTS WITH METASTATIC COLORECTAL CANCER +++ THE FIRST PATIENT IS RANDOMIZED IN UKRAINE INTO PHASE III STUDY IN PATIENTS WITH PRIMARY PROGRESSIVE OR RELAPSE-FREE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS +++ MAY 2016 : THE FIRST PATIENT IS RANDOMIZED IN UKRAINE INTO PHASE III STUDY IN PATIENTS WITH MULTIPLE SCLEROSIS +++ THE LAST PATIENT WAS RECRUITED AHEAD OF SCHEDULE INTO PHASE III STUDY IN PATIETS WITH ANGINA PECTORIS +++ 

About Us CRO Services Expertise Analytics Why Synergy Contact
[ About Us ] [ CRO Services ] [ Expertise ] [ Analytics ] [ Why?.. ]   [ Contact ]